A hypothetical adverse effect of insulin treatment on progression of NAFLD would be concerning, as NAFLD has been associated with an increased incidence of cardiovascular disease [7, 8] (although causality remains controversial [9, 10]), which accounts for the majority of deaths in T2DM [11]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.